Class 4 Caution in use-Moclobemide 150mg tablets

Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information.

MHRA drug alert Date: 25/11/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets, EL(25)A/50 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email QA@lexonuk.com, or telephone 01527 505 414. For stock control enquiries please email QA@lexonuk.com, or telephone 01527 505 414.

Class 3 recall- Fingolimod SUN 0.5mg hard capsules

CLASS 3 RECALL

Class 3 Recall from Sun Pharmaceutical Industries Limited

on Fingolimod SUN 0.5mg hard capsules

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-fingolimod-sun-0-dot-5mg-hard-capsules-el-25-a-slash-49?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=43ceb057-770e-45c5-b999-ad92df38ac1a&utm_content=immediately

MHRA ref: PL 31750/017

Reason: “Sun Pharma UK Limited is conducting a precautionary recall of a single batch of Fingolimod SUN 0.5 mg hard capsules due to reports of capsule breakage on removing from the blister. No other batches of Fingolimod SUN 0.5mg hard capsules are impacted.”

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050 / 07974754551.

For stock control enquiries please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Cencora Alliance Healthcare Raises Over £30,000 for Charities at annual Sports & Family Fun Day

Cencora Alliance Healthcare has raised over £30,000 for Cancer Research UK, Theodora Children’s Charity and Action Medical Research following its 2025 charity Sports Championship & Family Fun Day event.

Team members, friends and families joined the event located in Manchester and Wimbledon, to compete in competitive 5-a-side football tournaments and a charity netball match versus Theodora Children’s Charity.

Ellen Blessington, Communications Manager and Senior Fundraiser, Theodora Children’s Charity said: “We were delighted to once again be a part of this amazing event and play in the netball competition! Cencora Alliance Healthcare has supported the wellbeing of thousands of children living with illness by helping our Giggle Doctors bring music, magic, silliness and laughter to help improve children's hospital experience by reducing stress and anxiety and creating opportunities for play. Myself, along with Isabel from our Programme Team and Dr Fancy Pants had a fun filled day meeting all of the players, their families, and everyone that took part. Thank you so much for your kind support of our Giggle Doctors, Action Medical Research and Cancer Research UK, as we all work to help create healthier futures!”

Check out our 2025 Championship highlights video below 👇

Class 3 recall-Atorvastatin 20mg and 80mg Film-coated Tablet

Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-atorvastatin-20mg-and-80mg-film-coated-tablets-el-25-a-slash-48?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=99643300-1345-488a-afc4-eb384dcbc1d6&utm_content=immediately

MHRA drug alert date 11/11/25

Further Information

For all medical information enquiries and information on this product, please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050 / 07974754551.

For stock control enquiries please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Emylif 50mg orodispersible film

Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-zambon-spa-emylif-50mg-orodispersible-film-el-25-a-slash-47

MHRA drug alert date 10/11/25

Further Information

For all medical information enquiries and information on this product, please email infoUK@zambongroup.com, or telephone + 44 (0)800 0288 942.

For stock control enquiries please email infoUK@zambongroup.com, or telephone + 44 (0)800 0288 942.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Cencora Alliance Healthcare stand at The Pharmacy Show (UK)

The Pharmacy Show, the UK's largest trade show and education conference for the community and primary care pharmacy sector, once again brought the industry together in a vibrant celebration of innovation, learning, and collaboration.

Cencora team members proudly secured stand G35 with a vibrant Cencora Alliance Healthcare stand this year. The event saw over 8,500 healthcare and pharmacy professionals in attendance. With 300 exhibitors and more than 150 educational sessions led by over 200 speakers, it was a hub of ideas and insights designed to shape the future of pharmacy.

For Cencora, this year’s Pharmacy Show was particularly special. It marked our first time exhibiting in 12 years and served as the perfect stage to unveil our fresh branding. Our new identity—Cencora—represents our unwavering commitment to keeping the patient at the centre of everything we do, with ‘Cen’ symbolising the centre and ‘cora’ representing the heart. Our stand embodied this evolution, showcasing our expanded services and dedication to empowering pharmacy professionals. 

As part of our return, we proudly sponsored the Pharmacy Owners Forum, a cornerstone of the event that provided invaluable guidance on key topics such as revenue generation, expanding private services, and practical business advice. The forum also explored blueprints for business expansion, administrative and legal essentials, advertising strategies, weight management services, and understanding the rights and obligations of pharmacy owners. These sessions were designed to arm attendees with the tools and knowledge they need to grow their businesses and thrive in an ever-changing industry.

Among the many highlights, Mandeep Mudhar, Head of Alphega Pharmacy (UK) led a session on “The Importance of Creating Efficiencies and Headroom in Your Pharmacy”. His talk resonated deeply with attendees, offering actionable strategies to streamline operations and create space for growth in a demanding healthcare landscape.

Over the course of the two-day event, we engaged with an incredible number of visitors, capturing over 195 pieces of feedback and hot leads. It was inspiring to see so many healthcare professionals stopping by our stand to share how much they enjoy working with us and to discuss how we can continue to support them in delivering exceptional care to their patients. 

The Pharmacy Show was not just an event - it was a moment of transformation, connection, and inspiration. For Cencora, it reaffirmed our mission and strengthened our resolve to be a trusted partner for the pharmacy community. As we look to the future, we are more committed than ever to driving innovation, supporting growth, and keeping the heart of healthcare - our patients -at the centre of all we do.

Class 2 recall- Compound Sodium Lactate Solution for Infusion BP (Hartmann's Solution for infusion) in Viaflo 1000ml

Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons labelled as Hartmann’s Solution may contain Ringer’s Solution 1000mL.

MHRA drug alert linkhttps://www.gov.uk/drug-device-alerts/class-2-medicines-recall-baxter-healthcare-limited-compound-sodium-lactate-solution-for-infusion-bp-hartmanns-solution-for-infusion-in-viaflo-1000ml-el-25-a-slash-46?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=4134130c-5221-48d2-8fe8-bc296bb64f23&utm_content=immediately

MHRA drug alert date 28/10/25

Further Information

For all medical information enquiries and information on this product, please email Medinfo_UKI@baxter.com, or telephone 0800 0260514. 

For stock control enquiries please email victoria_franklin@baxter.com, or telephone +44 07825 374866. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution

Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-ipratropium-bromide-500-microgram-slash-2ml-nebuliser-solution-el-25-a-slash-45?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3205dad9-9795-48a8-bfca-a50aae5041c2&utm_content=immediately

MHRA drug alert date 23/10/25

Further Information

For all medical information enquiries and information on this product, please email Accord-UK Medical Information Department medinfo@accord-healthcare.com, or telephone 01271 385257.

For stock control enquiries please email Accord-UK Customer Services Team customerservices@accord-healthcare.com, or telephone 0800 373573.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use- Relonchem Ltd, Various Products

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error.

MHRA drug alert date 23/10/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please email medicalinformation@relonchem.com, or telephone 0151 556 1860.

For stock control enquiries please email medicalinformation@relonchem.com, or telephone 0151 556 1860.

Cencora Alliance Healthcare – Wholesaler of the Year Award by Pharmacy Business

Pharmacy Business – the voice of community pharmacy, announced Cencora Alliance Healthcare the inaugural winner of the Wholesaler of the Year Award (2025).

The Pharmacy Business Awards, celebrating 25 years of excellence took place on Friday 3 October, at the Park Plaza Westminster Bridge, London. The evening, enjoyed by hundreds of talented healthcare professionals, celebrated the very best in community pharmacy, as well as recognising organisations that support healthcare in the UK.

Paula Sutherland, Sales Director, Cencora Alliance Healthcare took to the stage on behalf of the business to receive the award, presented by Kalpesh and Shailesh Ramniklal Solanki, Group Managing Editor and Executive Editor, Pharmacy Business.

Reflecting on the award, Marie Evans, Managing Director and SVP said: "This is a wonderful recognition of all the teams hard work and commitment. This award from the pharmacy industry demonstrates our progress in listening to our customers to deliver the service that they deserve.”

Paula soon returned to the stage to present the Enterprise Award, sponsored by Cencora Alliance Healthcare, recognising the pharmacy with the most enterprising venture in any area of pharmacy.

The winner was Muhammad Shuaib of Biddulph Pharmacy: Innovation and thinking outside the box are the winner’s forte, which they demonstrated by identifying local healthcare gaps and developing practical, innovative solutions. When the nearby town had no Sunday pharmacy provision despite a minor injuries unit and out-of-hours prescribing, he partnered with a taxi firm to run a free shuttle service.

Congratulations to all the award winners on the night.